SORT BY

FILTER BY

also on other fortune lists

company facts

g500 stats

Global 500

Qilai Shen—Bloomberg via Getty Images

186

Novartis

NVS

Switzerland

Looking for leads, investment insights, or competitive intelligence?

CEO

Joseph Jimenez

Sector

Health Care

Industry

Pharmaceuticals

HQ Location

Basel, Switzerland

Years on Global 500 List

23

Employees

118,393

Figures prepared in accordance with International Accounting Standards.
Key Financials (Last Fiscal Year)
($ Millions)% change
Revenues ($M)$49,436-3.1%
Profits ($M)$6,712.0-62.3%
Assets ($M)$130,124
Total Stockholder Equity ($M)$74,832
Profit Ratios
Profit as % of Revenues13.6%
Profits as % of Assets5.2%
Profits as % of Stockholder Equity9.0%
STOCK QUOTE
()0.00 0.00 (0)
  • Previous Close:
  • Market Cap: NaNB
  • Next Earnings Date:
  • High:
  • Low:
  • 52 Week High:
  • 52 Week Low:
  • 52 Week Change %: 0.00
  • P/E Ratio: n/a
  • EPS:
  • Dividend Yield: n/a

News about Novartis

The Diseases We Aren't Curing—And Why

Drug makers are flocking to certain treatment types. Why do others get left behind?

Read More →
Commentary: How We Can Bring Health Care to the World’s Underserved

Half the world’s population lacks access to essential health services.

Read More →
Why Analysts Are Calling Celgene's $9 Billion Juno Acquisition a 'Smart' Biotech Deal

Juno's stock is up a staggering 76% since rumors of the Celgene deal emerged last week.

Read More →
2017 Saw the Most New Drugs Approved in Over 20 Years

The FDA approved 46 novel drugs in 2017 versus 22 in 2016.

Read More →